Skip to main content
All lobbying filings

Brownstein Hyatt Farber Schreck, LLP

Brownstein Hyatt Farber Schreck, LLP filed a Q4 report for Cardinal Health, Inc. on January 15, 2026, reporting $60,000 in lobbying income.

Lobbying for Cardinal Health, Inc. · Health care services company

As filed: BROWNSTEIN HYATT FARBER SCHRECK, LLP for CARDINAL HEALTH, INC.

All filings by Brownstein Hyatt Farber Schreck, LLP · Everything Cardinal Health, Inc. has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 15, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Ohio

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. The Preserving Patient Access to Long-Term Care Pharmacies Act (H.R. 5031 / S. 3159)

 Bills named in this filing 2
  • H.R. 5031
    Preserving Patient Access to Long-Term Care Pharmacies Act
  • S. 3159
    Preserving Patient Access to Long-Term Care Pharmacies Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem